People

The Medicon Valley Inhalation Consortium (MVIC) has announced that Ola Nerbrink has succeeded Orest Lastow as CEO. Nerbrink was previously MVIC's VP of Business Development. Lastow, who founded MVIC in 2012, left the position in May 2014 to become CEO of device developer Iconovo. That company has now entered into a collaboration agreement with MVIC, Nerbrink … [Read more...] about Medicon Valley Inhalation Consortium announces new CEO

The United States Pharmacopeial Convention (USP) has announced three recipients of its 2014–2015 Global Fellowship Awards. One of the recipients of the $30,000 fellowship, Ahmed Shalash of Alexandria University in Alexandria, Egypt, is researching carriers for dry powder inhaler formulations. According to USP, "The research deals with investigation of the role of … [Read more...] about USP awards fellowship for DPI research

CDMO Formex, LLC has announced that former Azo Pharma VP of Formulation Development John McCarty has joined the company as Scientific Advisor. McCarty will also serve as a member of the company's Science Advisory Board. Formex cites McCarty's "broad expertise in the development of all major dosage forms" and "over 17" patents. Formex Chief Scientific Officer J. … [Read more...] about Formex LLC hires John McCarty as Scientific Advisor

Theravance has announced that Michael W. Aguiar will replace Rick E Winningham as President and CEO effective August 15, 2014. Winningham will become CEO of Theravance Biopharma full time and will continue as Chairman of the Board of Directors of Theravance, Inc. Aguiar, who is currently Senior VP and Chief Financial Officer, joined Theravance in 2005 and led the … [Read more...] about Theravance appoints Michael W. Aguiar President and CEO

Canadian pharmaceutical company Milestone Pharmaceuticals, which is developing an intranasal short-acting calcium channel antagonist for the treatment of paroxysmal supraventricular tachycardia, has announced the appointment of Francis Plat as Chief Medical Officer. Dr. Plat commented, "I am highly enthused to join Milestone in its development of MSP-2017, a … [Read more...] about Milestone Pharmaceuticals appoints Francis Plat as Chief Medical Officer

Theravance has announced the appointment of Theodore J. Witek, Jr. as Senior VP Corporate Partnerships, Clinical and Medical Affairs. In that capacity, the company says Witek "will be focused on the further development of the respiratory programs partnered with Glaxo Group Limited (GSK)," including the Anoro and Breo/Ellipta DPIs. Witek was most recently President and … [Read more...] about Theravance appoints Theodore J. Witek Senior VP Corporate Partnerships, Clinical and Medical Affairs

Alexza Pharmaceuticals has promoted Edwin S. Kamemoto from VP, Regulatory Affairs to the newly created position of Senior VP, Regulatory Affairs. He was hired in 2006 as Associate Director, Regulatory Affairs; and promoted to Director, Regulatory Affairs, then to Senior Director, Regulatory Affairs, and then, in 2010, to Executive Director, Regulatory Affairs. … [Read more...] about Alexza names Edwin S. Kamemoto as Senior VP of Regulatory Affairs

Device component company Presspart Manufacturing has announced that former Lupin pulmonary research scientist Abhay Singh and former Sanofi QC readiness analyst Jacqueline Green have joined Presspart's Inhalation Product Technology Centre (IPTC) team. Singh has been hired as Senior Analyst, Green as Research Analyst. In late 2012, Presspart announced that it had … [Read more...] about Presspart adds two to its Inhalation Product Technology Centre team

OptiNose has announced three hires for senior management positions, which it says "will help drive the company forward in its mission to introduce new and valuable treatment options to the market utilizing its novel Bi-Directional Breath Powered Delivery Technology." The company has hired Ramona Lloyd as VP, Regulatory Affairs & Quality; Sheila Bergey as VP, … [Read more...] about OptiNose announces senior management additions